| Individuals younger than 65 years old | ||||||||
---|---|---|---|---|---|---|---|---|---|
 | All countries | High-GDP countries | Low-GDP countries | ||||||
 | Working | Not working | P valuea | Working | Not working | P valuea | Working | Not working | P valuea |
Number | 2,590 | 2,903 | Â | 1,436 | 1,347 | Â | 1,154 | 1,556 | Â |
Patient characteristics | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Females, percentage | 76% | 85% | < 0.001 | 72% | 81% | < 0.001 | 82% | 89% | < 0.001 |
   Age in years, mean | 46 | 52 | < 0.001 | 47 | 54 | < 0.001 | 45 | 50 | < 0.001 |
   Disease duration in years, mean | 8.3 | 11 | < 0.001 | 8.7 | 12 | < 0.001 | 7.8 | 11 | < 0.001 |
   Rheumatoid factor-positive, percentage | 72% | 75% | 0.004 | 70% | 75% | 0.001 | 75% | 76% | 0.64 |
   Erosive disease, percentage | 53% | 65% | < 0.001 | 51% | 62% | < 0.001 | 56% | 69% | < 0.001 |
Disease activity measures | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   DAS28 (0 to 9.1), mean | 4.0 | 4.6 | < 0.001 | 3.3 | 3.9 | < 0.001 | 4.8 | 5.2 | < 0.001 |
   ESR, median | 20 | 26 | < 0.001 | 14 | 18 | < 0.001 | 28 | 32 | < 0.001 |
   SJC (0 to 28), median | 2 | 3 | < 0.001 | 1 | 2 | < 0.001 | 3 | 4 | 0.002 |
   TJC (0 to 28), median | 3 | 5 | < 0.001 | 1 | 2 | < 0.001 | 7 | 8 | < 0.001 |
   Physician global (0 to 10), median | 2.1 | 2.8 | < 0.001 | 1.5 | 1.9 | < 0.001 | 3.0 | 3.8 | < 0.001 |
Patient self-report | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   HAQ physical function (0 to 3), median | 0.63 | 1.1 | < 0.001 | 0.50 | 0.88 | < 0.001 | 0.88 | 1.3 | < 0.001 |
   Pain VAS (0 to 10), median | 3.2 | 4.5 | < 0.001 | 2.3 | 3.8 | < 0.001 | 4.2 | 4.9 | < 0.001 |
   Patient global VAS (0 to 10), median | 3.3 | 4.6 | < 0.001 | 2.4 | 3.6 | < 0.001 | 4.3 | 5.0 | < 0.001 |
   Fatigue VAS (0 to 10), median | 3.9 | 4.8 | < 0.001 | 3.2 | 4.2 | < 0.001 | 4.5 | 5.2 | < 0.001 |
   Psychological HAQ (0 to 3), mean | 0.79 | 0.94 | < 0.001 | 0.60 | 0.82 | < 0.001 | 0.87 | 1.1 | < 0.001 |
Treatment-related variables | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Number of DMARDs ever taken, mean | 2.42 | 2.73 | < 0.001 | 2.6 | 3.1 | < 0.001 | 2.2 | 2.4 | < 0.001 |
   Biologics ever, percentage of patients | 22% | 21% | 0.60 | 32% | 35% | 0.12 | 8.5% | 9.0% | 0.65 |